HomeInsightsStock Comparison

Natco Pharma Ltd vs Zydus Lifesciences Ltd Stock Comparison

Natco Pharma Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Aug 05, 2025

Key Highlights

  • The Latest Trading Price of Natco Pharma Ltd is ₹ 931 as of 05 Aug 13:00.
  • The P/E Ratio of Natco Pharma Ltd changed from 20 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 19.7 on March 2025 . This represents a CAGR of -2.76% over 6 years.
  • The Market Cap of Natco Pharma Ltd changed from ₹ 9215 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 89122 crore on March 2025 . This represents a CAGR of 21.76% over 6 years.
  • The revenue of Natco Pharma Ltd for the Mar '25 is ₹ 1287 crore as compare to the Dec '24 revenue of ₹ 651.1 crore. This represent the growth of 97.71% The revenue of Zydus Lifesciences Ltd for the Mar '25 is ₹ 6608 crore as compare to the Dec '24 revenue of ₹ 5326 crore. This represent the growth of 24.07%.
  • The ebitda of Natco Pharma Ltd for the Mar '25 is ₹ 614.4 crore as compare to the Dec '24 ebitda of ₹ 215.1 crore. This represent the growth of 185.63% The ebitda of Zydus Lifesciences Ltd for the Mar '25 is ₹ 1986 crore as compare to the Dec '24 ebitda of ₹ 1444 crore. This represent the growth of 37.49%.
  • The net profit of Natco Pharma Ltd changed from ₹ 420.3 crore to ₹ 406 crore over 8 quarters. This represents a CAGR of -1.72% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1248 crore over 8 quarters. This represents a CAGR of 5.97% .
  • The Dividend Payout of Natco Pharma Ltd changed from 25.89 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 19.16 % on March 2025 . This represents a CAGR of -4.57% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Natco Pharma Ltd

  • Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited.
  • It became a deemed public company with effect from 1 July 1992.
  • The name of the company was changed to Natco Pharma Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC, Andhra Pradesh on 18 February 1993.
  • The company was converted into a public limited company and a fresh certificate of incorporation dated 30 December 1994 was issued by the RoC, Andhra Pradesh. Natco Pharma is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Natco Pharma Ltd News Hub

News

Natco Pharma's API unit in Mekaguda clears USFDA inspection

Natco Pharma announced that the U.S.FDA has issued Establishment Inspection Report (EIR) f...

Read more

24 Jul 2025 15:34

News

Natco Pharma receives USFDA EIR for Hyderabad API facility

The US FDA had conducted an inspection at the company's aforementioned unit from 9 June to...

Read more

24 Jul 2025 15:09

News

Natco Pharma Ltd spurts 0.35%, gains for five straight sessions

Natco Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 1036....

Read more

18 Jul 2025 13:00

News

Natco Pharma receives seven observations from USFDA Following Inspection at Kothur Facility

In a regulatory filing, the company stated that the USFDA conducted the inspection from 9 ...

Read more

20 Jun 2025 09:54

News

NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit

On conclusion of the inspection, the company received one observation in the Form-483. The...

Read more

14 Jun 2025 13:45

News

Natco Pharma's Mekaguda API unit completes USFDA inspection

NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active P...

Read more

13 Jun 2025 16:27

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences announces board meeting date

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Augu...

Read more

02 Aug 2025 09:52

News

Zydus Lifesciences Ltd soars 1.46%, gains for fifth straight session

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at R...

Read more

29 Jul 2025 13:00

News

Zydus Lifesciences gets USFDA Nod for Ibrutinib tablets

Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic...

Read more

24 Jul 2025 13:16

News

Zydus receives USFDA tentative approval for Ibrutinib tablets

Zydus Lifesciences has received tentative approval from the United States Food and Drug Ad...

Read more

24 Jul 2025 14:38

News

Zydus' Matoda facility completes Remote Regulatory Assessment of USFDA

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA)...

Read more

16 Jul 2025 17:55

News

Zydus Lifesciences gets USFDA Nod for Celecoxib Capsules

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing hormones ...

Read more

15 Jul 2025 15:45

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

SWOT Analysis Of Natco Pharma Ltd

Strength

4

S

Weakness

3

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Natco Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Natco Pharma Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Natco Pharma Ltd or Zydus Lifesciences Ltd?

Market cap of Natco Pharma Ltd is 16,752 Cr while Market cap of Zydus Lifesciences Ltd is 96,568 Cr

What are the key factors driving the stock performance of Natco Pharma Ltd and Zydus Lifesciences Ltd?

The stock performance of Natco Pharma Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Natco Pharma Ltd and Zydus Lifesciences Ltd?

As of August 5, 2025, the Natco Pharma Ltd stock price is INR ₹935.3. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹959.7.

How do dividend payouts of Natco Pharma Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Natco Pharma Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions